290 results
424B3
NKTR
Nektar Therapeutics
5 Jun 24
Prospectus supplement
5:30pm
antibodies and other materials that were developed pursuant to a research collaboration and license option agreement we entered into with Biolojic Design … website at http://www.sec.gov. You can also obtain copies of materials we file with the SEC from our website found at https://www.nektar.com. Information
DEFA14A
NKTR
Nektar Therapeutics
26 Apr 24
Additional proxy soliciting materials
4:10pm
Materials
Soliciting Material Pursuant to §240.14a-12
Nektar Therapeutics
(Name of Registrant as Specified In Its Charter)
(Name of Person(s … with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
D
g06 7we7a
19 Mar 24
$30.00 mm in equity / options, sold $30.00 mm, 1 investor
4:38pm
8-K
EX-10.1
obbjwuz2l0f gi
4 Mar 24
Entry into a Material Definitive Agreement
8:40am
DEFA14A
e4ww7
28 Apr 23
Additional proxy soliciting materials
12:00am
8-K
7gw4dl juggmc
27 Apr 23
Termination of a Material Definitive Agreement
8:40am
8-K
EX-99.1
6ga uot9ll1d
27 Apr 23
Termination of a Material Definitive Agreement
8:40am
8-K
EX-3.1
jlrqyv3wg6y5deirxn
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:05pm